Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features.

Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features.

Item
http://www.wikidata.org/entity/Q41658924
Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach.A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapySurgical challenges in the treatment of a giant renal cell carcinoma with atypical presentation: A case report.Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma.A Three-Variable Model Predicts Short Survival in Patients With Newly Diagnosed Metastatic Renal Cell Carcinoma.Renal Cell Carcinoma Update: News from the AUA, EAU, and ASCO Annual Meetings 2011.Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review.Impact of smoking status on survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy.Comparison of pre-treatment MSKCC and IMDC prognostic risk models in patients with synchronous metastatic renal cell carcinoma treated in the era of targeted therapy.Role of cytoreductive nephrectomy in the targeted therapy era: A systematic review and meta-analysis.Prognostic significance of nephrectomy in metastatic renal cell carcinoma treated with systemic cytokine or targeted therapy: A 16-year retrospective analysis.Minimally invasive cytoreductive nephrectomy: a multi-institutional experience.[Should cytoreductive nephrectomy be performed in patients with metastatic renal cell carcinoma and what is the scientific rationale?]Predictive value of inflammation-based prognostic scores in patients with metastatic renal cell carcinoma treated with cytoreductive nephrectomy.
P2860

Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features.

Item
http://www.wikidata.org/entity/Q41658924
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nephrectomy improves overall s ...... C or ECOG prognostic features.
@en
type
label
Nephrectomy improves overall s ...... C or ECOG prognostic features.
@en
prefLabel
Nephrectomy improves overall s ...... C or ECOG prognostic features.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Nephrectomy improves overall s ...... C or ECOG prognostic features.
@en
P2093
P304
P31
P356
10.1016/J.UROLONC.2015.05.014
P433
P478
P50
P577
P698